
HOME > Sponsorship > Our Sponsors
Bayer Korea Ltd.
Bracco Imaging Korea
Siemens Healthineers Ltd.
PHILIPS Korea
Guerbet Korea
GE HealthCare
Dongkook Lifescience
UIH Korea
Canon
WiTH Healthcare
CMS Pharmaceutical
ivy-lab
Korea Research Institute of Standards and Science
Bruker Korea Co.,Ltd
Bracco Imaging is a global leader in diagnostic imaging, headquartered in Milan, Italy. Since 1927, Bracco has been at the forefront of the industry, dedicated to shaping the future of prevention and precision imaging through a comprehensive portfolio of imaging agents and medical technologies. With a presence in over 100 countries and a strong commitment to Research & Development, the group provides innovative solutions that enhance clinical decision-making and patient care worldwide.
Bracco Imaging Korea, the local subsidiary of Bracco Imaging S.p.A., provides the Korean medical community with an integrated range of diagnostic imaging solutions. Our portfolio includes advanced contrast agents for CT, MRI, and Ultrasound, seamlessly integrated with our state-of-the-art contrast delivery systems and medical software. Notably, we recently introduced Vueway® (gadopiclenol), a next-generation macrocyclic MRI contrast agent that sets a new standard in diagnostic value with its high relaxivity. By combining cutting-edge products with proven technology, Bracco Imaging Korea remains committed to optimizing clinical workflows and ensuring patient safety.
Dongkook Lifescience. Co,. Ltd. is a specialized pharmaceutical company for diagnostic medicine and medical device. We are providing the most widely used Iopamidol product(Pamiray®) in Korea. Also, we export contrast media to EU and Japan about 20 million US dollar.
Dongkook Lifescience promises to strive to have competitive power in order to be a reliable corporate of domestic and foreign customer.
Our company motto is creation, harmony and trust. Creation means the origination of higher value added by development of the individual’s abilities. Harmony means the harmonious teamwork of these abilities. Based on the principal above, the things gain from the fulfillment of customer expectation is the trust. In addition, our final goal – respect for life and healthy life of the nation – settled the policy of the company, Human & Life.
Philips has shaped the future of healthcare since 1891 in the belief that there is always a way to make life better.
From CT and MR to Ultrasound, X-ray and IGT, our entire imaging portfolio aims to give care providers the right image at the right time, to support a faster, more confident diagnosis.
We also have helped our customers solve complex challenges, identify new opportunities and create future-ready solutions. We are driven to help our customers achieve its goals—technical, clinical and business—today and for years to come.
SIGNA™ MR enhances your MRI capabilities with efficient workflow and productivity solutions for routine scanning and brings innovation for advanced clinical procedures, all while keeping patient satisfaction at the forefront.
Guerbet is a pharmaceutical group specialized in medical imaging providing contrast media for diagnostic purposes. The company’s origin is linked to Marcel Guerbet’s discovery of the first organic iodinated contrast medium in 1901, Lipiodol®.
The Guerbet company was created in 1926 by André Guerbet. Since then, the company’s significant growth has been driven by regular innovations in medical imaging technologies accompanied by the introduction of new contrast media.
Over the last 40 years, Guerbet’s own research and development resulted in the launching of major products: Elucirem™, Dotarem® and Xenetix®
Bayer Radiology as the worldwide market leader in diagnostic imaging, continues to drive forward innovation in CT & MRI. We are providing Ultravist®, a guideline changing, quality & safety proven contrast media with up to date clinical data for CT and X-ray, Gadovist® 1.0, 1.0 M MRI contrast agent with high relaxivity and safety-proven data for all ages (incl. neonate) & whole body indication and Primovist®, an outstanding liver specific MRI contrast medium.
Now with the new business model from Bayer Radiology, we are continuously evolving our portfolio: including contrast media, we are expanding our business with medical devices thriving to become ‘The Solution Provider’.